vs

Side-by-side financial comparison of COGNEX CORP (CGNX) and NOVANTA INC (NOVT). Click either name above to swap in a different company.

NOVANTA INC is the larger business by last-quarter revenue ($258.3M vs $252.3M, roughly 1.0× COGNEX CORP). COGNEX CORP runs the higher net margin — 12.9% vs 6.8%, a 6.2% gap on every dollar of revenue. On growth, COGNEX CORP posted the faster year-over-year revenue change (9.9% vs 8.5%). COGNEX CORP produced more free cash flow last quarter ($72.3M vs $5.1M). Over the past eight quarters, COGNEX CORP's revenue compounded faster (9.4% CAGR vs 5.8%).

Cognex Corporation is an American manufacturer of machine vision systems, software and sensors. Cognex is headquartered in Natick, Massachusetts, USA with offices in more than 20 countries.

Novanta Inc is a global technology supplier delivering high-precision photonics, motion control, and machine vision solutions. It serves core segments including medical equipment manufacturing, advanced industrial automation, robotics, and life sciences, helping customers boost product performance and drive innovation worldwide.

CGNX vs NOVT — Head-to-Head

Bigger by revenue
NOVT
NOVT
1.0× larger
NOVT
$258.3M
$252.3M
CGNX
Growing faster (revenue YoY)
CGNX
CGNX
+1.3% gap
CGNX
9.9%
8.5%
NOVT
Higher net margin
CGNX
CGNX
6.2% more per $
CGNX
12.9%
6.8%
NOVT
More free cash flow
CGNX
CGNX
$67.2M more FCF
CGNX
$72.3M
$5.1M
NOVT
Faster 2-yr revenue CAGR
CGNX
CGNX
Annualised
CGNX
9.4%
5.8%
NOVT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CGNX
CGNX
NOVT
NOVT
Revenue
$252.3M
$258.3M
Net Profit
$32.7M
$17.5M
Gross Margin
65.7%
43.8%
Operating Margin
14.0%
9.6%
Net Margin
12.9%
6.8%
Revenue YoY
9.9%
8.5%
Net Profit YoY
15.2%
6.1%
EPS (diluted)
$0.20
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGNX
CGNX
NOVT
NOVT
Q4 25
$252.3M
$258.3M
Q3 25
$276.9M
$247.8M
Q2 25
$249.1M
$241.0M
Q1 25
$216.0M
$233.4M
Q4 24
$229.7M
$238.1M
Q3 24
$234.7M
$244.4M
Q2 24
$239.3M
$235.9M
Q1 24
$210.8M
$230.9M
Net Profit
CGNX
CGNX
NOVT
NOVT
Q4 25
$32.7M
$17.5M
Q3 25
$17.7M
$10.7M
Q2 25
$40.5M
$4.5M
Q1 25
$23.6M
$21.2M
Q4 24
$28.3M
$16.5M
Q3 24
$29.6M
$19.2M
Q2 24
$36.2M
$13.8M
Q1 24
$12.0M
$14.7M
Gross Margin
CGNX
CGNX
NOVT
NOVT
Q4 25
65.7%
43.8%
Q3 25
67.6%
44.8%
Q2 25
67.4%
44.3%
Q1 25
66.8%
44.7%
Q4 24
68.7%
45.5%
Q3 24
67.9%
44.7%
Q2 24
69.6%
44.0%
Q1 24
67.3%
43.5%
Operating Margin
CGNX
CGNX
NOVT
NOVT
Q4 25
14.0%
9.6%
Q3 25
20.9%
8.8%
Q2 25
17.4%
6.2%
Q1 25
12.1%
13.9%
Q4 24
13.4%
11.2%
Q3 24
13.4%
13.3%
Q2 24
16.1%
10.9%
Q1 24
6.7%
11.1%
Net Margin
CGNX
CGNX
NOVT
NOVT
Q4 25
12.9%
6.8%
Q3 25
6.4%
4.3%
Q2 25
16.3%
1.9%
Q1 25
10.9%
9.1%
Q4 24
12.3%
6.9%
Q3 24
12.6%
7.9%
Q2 24
15.1%
5.8%
Q1 24
5.7%
6.4%
EPS (diluted)
CGNX
CGNX
NOVT
NOVT
Q4 25
$0.20
$0.46
Q3 25
$0.10
$0.30
Q2 25
$0.24
$0.12
Q1 25
$0.14
$0.59
Q4 24
$0.17
$0.45
Q3 24
$0.17
$0.53
Q2 24
$0.21
$0.38
Q1 24
$0.07
$0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGNX
CGNX
NOVT
NOVT
Cash + ST InvestmentsLiquidity on hand
$262.9M
$380.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.5B
$1.3B
Total Assets
$2.0B
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGNX
CGNX
NOVT
NOVT
Q4 25
$262.9M
$380.9M
Q3 25
$245.9M
$89.2M
Q2 25
$179.3M
$109.9M
Q1 25
$143.7M
$106.0M
Q4 24
$186.1M
$114.0M
Q3 24
$197.1M
$92.7M
Q2 24
$176.6M
$98.5M
Q1 24
$138.9M
$93.5M
Stockholders' Equity
CGNX
CGNX
NOVT
NOVT
Q4 25
$1.5B
$1.3B
Q3 25
$1.5B
$801.5M
Q2 25
$1.5B
$801.4M
Q1 25
$1.4B
$769.8M
Q4 24
$1.5B
$745.7M
Q3 24
$1.6B
$742.2M
Q2 24
$1.5B
$702.0M
Q1 24
$1.5B
$681.7M
Total Assets
CGNX
CGNX
NOVT
NOVT
Q4 25
$2.0B
$1.8B
Q3 25
$2.0B
$1.5B
Q2 25
$2.0B
$1.5B
Q1 25
$1.9B
$1.4B
Q4 24
$2.0B
$1.4B
Q3 24
$2.1B
$1.4B
Q2 24
$2.0B
$1.4B
Q1 24
$2.0B
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGNX
CGNX
NOVT
NOVT
Operating Cash FlowLast quarter
$74.9M
$8.8M
Free Cash FlowOCF − Capex
$72.3M
$5.1M
FCF MarginFCF / Revenue
28.7%
2.0%
Capex IntensityCapex / Revenue
1.0%
1.4%
Cash ConversionOCF / Net Profit
2.29×
0.50×
TTM Free Cash FlowTrailing 4 quarters
$236.8M
$48.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGNX
CGNX
NOVT
NOVT
Q4 25
$74.9M
$8.8M
Q3 25
$87.5M
$8.5M
Q2 25
$42.6M
$15.1M
Q1 25
$40.5M
$31.7M
Q4 24
$51.4M
$61.6M
Q3 24
$56.3M
$23.0M
Q2 24
$27.8M
$41.1M
Q1 24
$13.6M
$32.8M
Free Cash Flow
CGNX
CGNX
NOVT
NOVT
Q4 25
$72.3M
$5.1M
Q3 25
$86.0M
$4.2M
Q2 25
$40.4M
$11.7M
Q1 25
$38.0M
$27.4M
Q4 24
$49.3M
$59.3M
Q3 24
$51.9M
$19.5M
Q2 24
$23.3M
$36.2M
Q1 24
$9.6M
$26.4M
FCF Margin
CGNX
CGNX
NOVT
NOVT
Q4 25
28.7%
2.0%
Q3 25
31.1%
1.7%
Q2 25
16.2%
4.8%
Q1 25
17.6%
11.7%
Q4 24
21.5%
24.9%
Q3 24
22.1%
8.0%
Q2 24
9.7%
15.3%
Q1 24
4.5%
11.4%
Capex Intensity
CGNX
CGNX
NOVT
NOVT
Q4 25
1.0%
1.4%
Q3 25
0.5%
1.7%
Q2 25
0.9%
1.4%
Q1 25
1.2%
1.8%
Q4 24
0.9%
0.9%
Q3 24
1.9%
1.5%
Q2 24
1.9%
2.1%
Q1 24
1.9%
2.8%
Cash Conversion
CGNX
CGNX
NOVT
NOVT
Q4 25
2.29×
0.50×
Q3 25
4.95×
0.80×
Q2 25
1.05×
3.35×
Q1 25
1.72×
1.49×
Q4 24
1.81×
3.74×
Q3 24
1.90×
1.20×
Q2 24
0.77×
2.99×
Q1 24
1.13×
2.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons